Brief: China Grand Pharmaceutical And Healthcare Says HY Profit Attributable Hk$1,202.54 Million
10/08/2021 12:25
Aug 10 (Reuters) - China Grand Pharmaceutical and Healthcare
Holdings Ltd 0512.HK :
* CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS LTD
SAYS HY
PROFIT ATTRIBUTABLE HK$1,202.54 MILLION VERSUS HK$718.51 MILLION
* CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS LTD
SAYS HY
REVENUE HK$4,566.53 MILLION VERSUS HK$3,255.78 MILLION
Source text for Eikon: ID:nHKS1kcx5B
Further company coverage: 0512.HK
(Reuters.briefs@thomsonreuters.com)
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement